GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aarti Pharmalabs Ltd (BOM:543748) » Definitions » EV-to-Revenue

Aarti Pharmalabs (BOM:543748) EV-to-Revenue : 3.00 (As of Dec. 12, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Aarti Pharmalabs EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Aarti Pharmalabs's enterprise value is ₹58,010 Mil. Aarti Pharmalabs's Revenue for the trailing twelve months (TTM) ended in Sep. 2024 was ₹19,309 Mil. Therefore, Aarti Pharmalabs's EV-to-Revenue for today is 3.00.

The historical rank and industry rank for Aarti Pharmalabs's EV-to-Revenue or its related term are showing as below:

BOM:543748' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.36   Med: 2.35   Max: 3.3
Current: 3.06

During the past 4 years, the highest EV-to-Revenue of Aarti Pharmalabs was 3.30. The lowest was 1.36. And the median was 2.35.

BOM:543748's EV-to-Revenue is ranked worse than
57.44% of 994 companies
in the Drug Manufacturers industry
Industry Median: 2.48 vs BOM:543748: 3.06

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-12-12), Aarti Pharmalabs's stock price is ₹608.95. Aarti Pharmalabs's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 was ₹213.01. Therefore, Aarti Pharmalabs's PS Ratio for today is 2.86.


Aarti Pharmalabs EV-to-Revenue Historical Data

The historical data trend for Aarti Pharmalabs's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aarti Pharmalabs EV-to-Revenue Chart

Aarti Pharmalabs Annual Data
Trend Mar21 Mar22 Mar23 Mar24
EV-to-Revenue
- - 1.36 2.28

Aarti Pharmalabs Quarterly Data
Mar21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.32 2.51 2.28 2.89 3.14

Competitive Comparison of Aarti Pharmalabs's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Aarti Pharmalabs's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aarti Pharmalabs's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aarti Pharmalabs's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Aarti Pharmalabs's EV-to-Revenue falls into.



Aarti Pharmalabs EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Aarti Pharmalabs's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=58010.108/19308.744
=3.00

Aarti Pharmalabs's current Enterprise Value is ₹58,010 Mil.
Aarti Pharmalabs's Revenue for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹19,309 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aarti Pharmalabs  (BOM:543748) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Aarti Pharmalabs's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=608.95/213.011
=2.86

Aarti Pharmalabs's share price for today is ₹608.95.
Aarti Pharmalabs's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹213.01.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aarti Pharmalabs EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Aarti Pharmalabs's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Aarti Pharmalabs Business Description

Traded in Other Exchanges
Address
Mulund Goregaon Link Road, 2nd floor, 204, Udyog Kshetra, Mulund West, Mumbai, MH, IND, 400080
Aarti Pharmalabs Ltd manufactures pharmaceuticals and nutraceuticals with a footprint. It manufactures Active Pharmaceutical Ingredients (API), pharmaceutical intermediates, and xanthine derivatives in India. It also offers Contract Development and Manufacturing Services (CDMS) for drug substance (NCE, RSM, Intermediates) projects. Geographically, the company generates maximum revenue from its customers located outside India.

Aarti Pharmalabs Headlines

No Headlines